arrow_back Back to App

Lowering Chronic Drug Costs for Seniors in Medicare Part D.

This law aims to reduce drug costs for seniors on Medicare Part D who use specific chronic care medications. Starting in 2027, if you pay a percentage of the drug price (coinsurance), it must be calculated based on the actual, lower price after manufacturer rebates are factored in. This change is designed to decrease out-of-pocket expenses for essential chronic treatments.
Key points
The change applies specifically to selected chronic care drugs, including certain heart medications, anticoagulants, respiratory agents, and non-insulin blood glucose regulators.
Coinsurance payments will be based on the "net price" of the drug—the price after all manufacturer rebates and concessions are deducted.
Effective January 1, 2027, this ensures seniors are not paying a percentage based on an inflated drug price.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2770
Sponsor: Sen. Cornyn, John [R-TX]
Process start date: 2025-09-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Share the Savings with Seniors Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2770.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-11.

What are the main provisions?

Key points include:

  • The change applies specifically to selected chronic care drugs, including certain heart medications, anticoagulants, respiratory agents, and non-insulin blood glucose regulators.
  • Coinsurance payments will be based on the "net price" of the drug—the price after all manufacturer rebates and concessions are deducted.
  • Effective January 1, 2027, this ensures seniors are not paying a percentage based on an inflated drug price.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cornyn, John [R-TX].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

CATEGORIES

Health Benefits